M. Rossi

发表

Fungal Infections in Children With Cancer: A Prospective, Multicenter Surveillance Study

S. Parodi, C. Viscoli, N. Santoro, 2006, The Pediatric infectious disease journal.

A multicenter, randomized, double blind placebo-controlled trial of amoxicillin/clavulanate for the prophylaxis of fever and infection in neutropenic children with cancer

P. Bruzzi, L. Boni, C. Viscoli, 2003, The Pediatric infectious disease journal.

Fluconazole versus amphotericin B as empirical antifungal therapy of unexplained fever in granulocytopenic cancer patients: a pragmatic, multicentre, prospective and randomised clinical trial.

C. Viscoli, A. Garaventa, E. Castagnola, 1996, European journal of cancer.

Empiric antimicrobial therapy for febrile granulocytopenic cancer patients: lessons from four EORTC trials.

M. Tattersall, T. Calandra, C. Viscoli, 1988, European journal of cancer & clinical oncology.

PTX3 as a Potential Novel Tool for the Diagnosis and Monitoring of Pulmonary Fungal Infections in Immuno-compromised Pediatric Patients

A. Mantovani, D. Silvestri, G. Peri, 2008, Journal of pediatric hematology/oncology.

Outpatient management of febrile neutropenia in children with cancer

F. Tucci, O. Ziino, M. Rossi, 2011, Pediatric reports.

Bmc Infectious Diseases Safety and Efficacy of a Caspofungin-based Combination Therapy for Treatment of Proven or Probable Aspergillosis in Pediatric Hematological Patients

F. Locatelli, B. Buldini, M. Spiller, 2022 .

Incidence of bacteremias and invasive mycoses in children with acute non‐lymphoblastic leukemia: Results from a multi‐center Italian study

M. Putti, R. Haupt, F. Fioredda, 2010, Pediatric blood & cancer.

Preventing transmission of infectious agents in the pediatric in-patients hematology-oncology setting: what is the role for non-pharmacological prophylaxis?

M. Aricò, E. Castagnola, S. Cesaro, 2011, Pediatric reports.

Zygomycosis in Italy: A Survey of FIMUA-ECMM (Federazione Italiana Di Micopatologia Umana ed Animale and European Confederation of Medical Mycology)

C. Romano, A. d’Arminio Monforte, L. Pagano, 2009, Journal of chemotherapy.

Italian Guidelines for the Management of Infectious Complications in Pediatric Oncology: Empirical Antimicrobial Therapy of Febrile Neutropenia

G. Masera, C. Viscoli, N. Santoro, 1998, Oncology.

Prolonged extracorporeal membrane oxygenation therapy for severe acute respiratory distress syndrome in a child affected by rituximab-resistant autoimmune hemolytic anemia: a case report

G. Foti, N. Patroniti, E. Biagi, 2009, Journal of medical case reports.

Preventing Transmission of Infectious Agents in the Pediatric In-patients Hematol- Ogy-oncology Setting: What Is the Role for Non- Pharmacological Prophylaxis? Elio Castagnola 13 for the Infection Study Group of the Associazione Italiana Ematologia Oncologia Pediatrica (aieop)

M. Aricò, E. Castagnola, S. Cesaro, 2022 .

High weekly doses of liposomal amphotericin B as secondary prophylaxis after cerebral aspergillosis in a paediatric patient

P. Brazzola, M. Rossi, 2013, Medical mycology case reports.

A survey on hematology-oncology pediatric AIEOP centers: prophylaxis, empirical therapy and nursing prevention procedures of infectious complications

A. Jenkner, G. Pontrelli, L. Folgori, 2012, Haematologica.

Pharmacokinetics of HD-MTX in infants, children, and adolescents with non-B acute lymphoblastic leukemia.

M. Zucchetti, M. D’Incalci, G. Masera, 1995, Medical and pediatric oncology.

Randomized multicentric Italian study on two treatment regimens for marrow relapse in childhood acute lymphoblastic leukemia.

F. Mandelli, G. Dini, M. Carli, 1986, Pediatric hematology and oncology.

Febrile complications in the first 100 days after bone marrow transplantation in children: a single center's experience.

M. Valsecchi, G. Masera, D. Silvestri, 1997, Pediatric hematology and oncology.